Tortoise Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-175
| Closed | -$17.2K | – | 1505 |
|
|
2025
Q3 | $17.2K | Buy |
175
+3
| +2% | +$297 | ﹤0.01% | 547 |
|
|
2025
Q2 | $15.7K | Buy |
172
+7
| +4% | +$677 | ﹤0.01% | 549 |
|
|
2025
Q1 | $18.7K | Hold |
165
| – | – | ﹤0.01% | 514 |
|
|
2024
Q4 | $17.4K | Hold |
165
| – | – | ﹤0.01% | 569 |
|
|
2024
Q3 | $17.8K | Hold |
165
| – | – | ﹤0.01% | 567 |
|
|
2024
Q2 | $17.9K | Hold |
165
| – | – | ﹤0.01% | 550 |
|
|
2024
Q1 | $21.8K | Hold |
165
| – | – | ﹤0.01% | 499 |
|
|
2023
Q4 | $20.1K | Hold |
165
| – | – | ﹤0.01% | 479 |
|
|
2023
Q3 | $18.5K | Hold |
165
| – | – | ﹤0.01% | 468 |
|
|
2023
Q2 | $24K | Hold |
165
| – | – | ﹤0.01% | 448 |
|
|
2023
Q1 | $21.3K | Hold |
165
| – | – | ﹤0.01% | 448 |
|
|
2022
Q4 | $21K | Hold |
165
| – | – | ﹤0.01% | 447 |
|
|
2022
Q3 | $17K | Hold |
165
| – | – | ﹤0.01% | 467 |
|
|
2022
Q2 | $17K | Hold |
165
| – | – | ﹤0.01% | 459 |
|
|
2022
Q1 | $21K | Sell |
165
-5
| -3% | -$603 | ﹤0.01% | 426 |
|
|
2021
Q4 | $21K | Hold |
170
| – | – | ﹤0.01% | 399 |
|
|
2021
Q3 | $24K | Hold |
170
| – | – | ﹤0.01% | 370 |
|
|
2021
Q2 | $27K | Hold |
170
| – | – | 0.01% | 343 |
|
|
2021
Q1 | $26K | Hold |
170
| – | – | 0.01% | 328 |
|
|
2020
Q4 | $25K | Hold |
170
| – | – | 0.01% | 309 |
|
|
2020
Q3 | $22K | Hold |
170
| – | – | 0.01% | 303 |
|
|
2020
Q2 | $20K | Hold |
170
| – | – | 0.01% | 303 |
|
|
2020
Q1 | $17K | Hold |
170
| – | – | ﹤0.01% | 312 |
|
|
2019
Q4 | $25K | Sell |
170
-51
| -23% | -$7.04K | 0.01% | 296 |
|
|
2019
Q3 | $30K | Hold |
221
| – | – | 0.01% | 276 |
|
|
2019
Q2 | $25K | Hold |
221
| – | – | 0.01% | 318 |
|
|
2019
Q1 | $27K | Hold |
221
| – | – | 0.01% | 302 |
|
|
2018
Q4 | $22K | Hold |
221
| – | – | 0.01% | 304 |
|
|
2018
Q3 | $28K | Hold |
221
| – | – | 0.01% | 288 |
|
|
2018
Q2 | $24K | Hold |
221
| – | – | 0.01% | 313 |
|
|
2018
Q1 | $23K | Sell |
221
-52
| -19% | -$6.04K | 0.01% | 313 |
|
|
2017
Q4 | $32K | Hold |
273
| – | – | 0.01% | 282 |
|
|
2017
Q3 | $31K | Hold |
273
| – | – | 0.01% | 266 |
|
|
2017
Q2 | $34K | Hold |
273
| – | – | 0.01% | 248 |
|
|
2017
Q1 | $32K | Hold |
273
| – | – | 0.01% | 236 |
|
|
2016
Q4 | $27K | Hold |
273
| – | – | 0.01% | 246 |
|
|
2016
Q3 | $34K | Sell |
273
-62
| -19% | -$7.66K | 0.01% | 223 |
|
|
2016
Q2 | $39K | Buy |
335
+62
| +23% | +$7.02K | 0.01% | 215 |
|
|
2016
Q1 | $28K | Hold |
273
| – | – | 0.01% | 232 |
|
|
2015
Q4 | $27K | Hold |
273
| – | – | 0.01% | 247 |
|
|
2015
Q3 | $25K | Hold |
273
| – | – | 0.01% | 242 |
|
|
2015
Q2 | $29K | Sell |
273
-103
| -27% | -$11.4K | 0.01% | 242 |
|
|
2015
Q1 | $43K | Hold |
376
| – | – | 0.02% | 220 |
|
|
2014
Q4 | $41K | Sell |
376
-11
| -3% | -$1.16K | 0.02% | 233 |
|
|
2014
Q3 | $38K | Hold |
387
| – | – | 0.02% | 227 |
|
|
2014
Q2 | $39K | Buy |
387
+11
| +3% | +$1.07K | 0.02% | 230 |
|
|
2014
Q1 | $35K | Hold |
376
| – | – | 0.02% | 208 |
|
|
2013
Q4 | $34K | Hold |
376
| – | – | 0.02% | 197 |
|
|
2013
Q3 | $30K | Hold |
376
| – | – | 0.02% | 183 |
|
|
2013
Q2 | $27K | Buy |
+376
| New | +$28.1K | 0.02% | 182 |
|
Other funds holding ZBH
Tortoise Investment Management's ZBH Position: Q4 2025 in Review
Tortoise Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 175 shares — an estimated $17.2K sold.
Tortoise Investment Management first reported a position in ZBH in Q2 2013 and held it in 50 quarters. The position peaked at $43K in Q1 2015. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Tortoise Investment Management reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- Tortoise Investment Management sold 175 Zimmer Biomet shares in Q4 2025, an estimated $17.2K.
- Tortoise Investment Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 50 quarters.
- Tortoise Investment Management's Zimmer Biomet position peaked at $43K in Q1 2015.
- 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.